View in EDS HTML Full Text PDF Full Text

Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.

Saved in:
Bibliographic Details
Title: Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
Authors: Nguyen TTA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA., Postlewait LM; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA., Zhang C; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, GA, USA., Meisel JL; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA., O'Regan R; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Badve S; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA., Kalinsky K; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA., Li X; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA. xli40@emory.edu.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Apr; Vol. 192 (3), pp. 509-516. Date of Electronic Publication: 2022 Jan 27.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35084624
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nguyen+TTA%22">Nguyen TTA</searchLink>; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Postlewait+LM%22">Postlewait LM</searchLink>; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Meisel+JL%22">Meisel JL</searchLink>; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22O'Regan+R%22">O'Regan R</searchLink>; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Badve+S%22">Badve S</searchLink>; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kalinsky+K%22">Kalinsky K</searchLink>; Department of Hematology and Oncology, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA. xli40@emory.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2022 Apr; Vol. 192 (3), pp. 509-516. <i>Date of Electronic Publication: </i>2022 Jan 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35084624
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-022-06530-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 509
    Titles:
      – TitleFull: Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nguyen TTA
      – PersonEntity:
          Name:
            NameFull: Postlewait LM
      – PersonEntity:
          Name:
            NameFull: Zhang C
      – PersonEntity:
          Name:
            NameFull: Meisel JL
      – PersonEntity:
          Name:
            NameFull: O'Regan R
      – PersonEntity:
          Name:
            NameFull: Badve S
      – PersonEntity:
          Name:
            NameFull: Kalinsky K
      – PersonEntity:
          Name:
            NameFull: Li X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 192
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1